Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. (Q36293343)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
scientific article

    Statements

    Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Dalil Hannani
    David Enot
    David Klatzmann
    Melanie Desbois
    Salem Chouaib
    Christine Mateus
    James P Allison
    Antoni Ribas
    Jedd D Wolchok
    Jianda Yuan
    Philip Wong
    Michael Postow
    Andrzej Mackiewicz
    Jacek Mackiewicz
    Dirk Schadendorff
    Dirk Jaeger
    Inka Zörnig
    Jessica Hassel
    Alan J Korman
    Keith Bahjat
    Michele Maio
    Luana Calabro
    Michele Wl Teng
    Mark J Smyth
    13 January 2015
    208-224

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit